LD-2 disclosure · 2nd Quarter - Report
ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)
Client
- Name
- ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)
- Location
- Delaware · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in FY 2017 appropriations bills; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee Chronic Disease Initiative; Implementation of Precision Medicine Initiative; White House Cancer Moonshot; Legislation affecting the ESRD program.
LobbyistsSUSAN HIRSCHMANN · GEORGE OLSEN · KARINA LYNCH · ms MELINDA M MAXFIELD · mr MATTHEW B HOEKSTRA · CHERYL LYNN JAEGER · ERIN BOOK MULLEN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Vice President of the U.S.
Taxation/Internal Revenue Code
Tax issues affecting the pharmaceutical industry, tax reform issues.
LobbyistsGEORGE OLSEN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Vice President of the U.S.
Medicare/Medicaid
Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB).